[China Southern Airlines Co., Ltd Corporate Social Responsibility Report 2016 March 30, 2017 TABLE OF CONTENTS 1. ABOUT THIS REPORT 5 2. STATEMENT OF THE GENERAL MANAGER 6 3. ABOUT US 8 3.1 Corporate Profile 8 3.2 Fleet and Network 10 3.3 Corporate Culture 12 3.4 Strategies and Governance 13 4. HIGHL]
[FORM 20-F (Mark One) o OR x OR o For the transition period from to OR o Date of event requiring this shell company report . . . . . . . . . . . . . . . . . . . 51job, Inc. N/A Cayman Islands (Jurisdiction of incorporation or organization) Building 3 No. 1387, Zhang Dong] [List of Subsidiaries and Af]
[TABLE OF CONTENTS INTRODUCTION 1 2 PART I 3 ITEM 1. IDENTITY OF DIRECTORS, SENIOR MANAGEMENT AND ADVISERS 3 ITEM 2. OFFER STATISTICS AND EXPECTED TIMETABLE 3 ITEM 3. KEY INFORMATION 3] [THE COMPANIES LAW (2016 REVISION) OF THE CAYMAN ISLANDS COMPANY LIMITED BY SHARES FOURTH AMENDED AND RESTATED MEMO]
[China Southern Airlines Co., Ltd Corporate Social Responsibility Report 2016 March 30, 2017 TABLE OF CONTENTS 1. ABOUT THIS REPORT 5 2. STATEMENT OF THE GENERAL MANAGER 6 3. ABOUT US 8 3.1 Corporate Profile 8 3.2 Fleet and Network 10 3.3 Corporate Culture 12 3.4 Strategies and Governance 13 4. HIGHL]
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ x ] Form 10-K [ For Period Ended: December 31, 2016 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transi]
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results HAIKOU CITY, China, March 31, 2017 - China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma,” the “Com]
[(a joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock Code: 1055) 2016 ANNUAL RESULTS The board of directors (the “Board”) of China Southern Airlines Company Limited (the “Company”) hereby announces the audited results of the Company and its sub]
[FORM 12b-25 NOTIFICATION OF LATE FILING (Check one): CUSIP NUMBER [ x ] Form 10-K [ For Period Ended: December 31, 2016 [ Transition Report on Form 10-K [ Transition Report on Form 20-F [ Transition Report on Form 11-K [ Transition Report on Form 10-Q [ Transition Report on Form N-SAR For the Transi]
[Contact: China Pharma Holdings, Inc. Ms. Diana Na Huang Phone: +86-898-6681-1730 (China) Email: hps@chinapharmaholdings.com China Pharma Holdings, Inc. Reports Full Year 2016 Financial Results HAIKOU CITY, China, March 31, 2017 - China Pharma Holdings, Inc. (NYSE MKT: CPHI) (“China Pharma,” the “Com]
